Neuropathic pain arises from disease or damage of the nervous system. It is a major clinical problem affecting 5-10% of the adult population, despite the use of current therapies.
The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium academically led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King\u2019s College London.
In a new study, neuroscientists have found that raised blood pressure and diabetes in mid-life alter brain structure to slow thinking speed and memory.
The Medical Research Council has awarded Alexander Thompson a prestigious five-year Lady Edith Wolfson MRC Clinician Scientist Fellowship to investigate the causes of amyotrophic lateral sclerosis (ALS, also known as motor neuron disease, MND).
Research carried out by George Tofaris and his team has led to the development of a new way to test for Parkinson\u2019s disease before the main symptoms occur. This could allow clinicians to identify patients who would benefit from precision therapies that are currently at clinical trial stage.
The NIHR Research and Innovation for Global Health Transformation (RIGHT) programme has awarded \u00a34.9 million to help fund a project investigating epilepsy in sub-Saharan Africa.
Dr Arjune Sen is leading a new six-month trial funded by the MRC Confidence in Concept scheme. The study is known as IliAD (Investigation of Levetiracetam in Alzheimer's Disease).
The Oxford Epilepsy Research Group is at the forefront of some potentially ground-breaking work with patients who have drug-resistant epilepsy. Epilepsy affects over 50 million people worldwide and nearly one in three people with epilepsy are resistant to current drugs.
![\"Pain](\"https://www.ndcn.ox.ac.uk/news/mrc-new-investigator-award-for-john-dawes/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n